Bridgepoint Group (LON:BPT) Stock Rating Upgraded by Citigroup

Citigroup upgraded shares of Bridgepoint Group (LON:BPT) to a buy rating in a report released on Thursday, Marketbeat reports. The brokerage currently has GBX 410 ($5.32) price objective on the stock.

Bridgepoint Group Price Performance

Shares of LON:BPT opened at GBX 338.40 ($4.39) on Thursday. The firm has a 50 day moving average of GBX 359.06 and a 200-day moving average of GBX 346.36. Bridgepoint Group has a 12 month low of GBX 202.40 ($2.62) and a 12 month high of GBX 410 ($5.32). The company has a current ratio of 4.98, a quick ratio of 3.60 and a debt-to-equity ratio of 12.89. The stock has a market capitalization of £2.79 billion, a PE ratio of 61.47, a PEG ratio of 0.61 and a beta of 1.72.

Bridgepoint Group (LON:BPT) last released its earnings results on Thursday, March 13th. The company reported GBX 19.50 ($0.25) earnings per share for the quarter. Bridgepoint Group had a return on equity of 6.10% and a net margin of 16.74%. On average, equities research analysts predict that Bridgepoint Group will post 17.4062165 EPS for the current fiscal year.

Bridgepoint Group Dividend Announcement

The firm also recently announced a dividend, which will be paid on Thursday, May 22nd. Shareholders of record on Thursday, April 24th will be paid a dividend of GBX 4.60 ($0.06) per share. This represents a yield of 1.43%. The ex-dividend date is Thursday, April 24th. Bridgepoint Group’s payout ratio is 163.50%.

Bridgepoint Group Company Profile

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.